Veeva Basics Gaining Traction among Biotech Firms
Veeva Systems (NYSE: VEEV) recently revealed a significant milestone: over 100 emerging biotech companies have adopted Veeva Basics to simplify and standardize their operational processes. Recognizing the need for efficiency, these firms are leveraging Veeva's innovative solutions to enhance their clinical, regulatory, and quality operations.
Streamlining Operations with Veeva Basics
Through Veeva Basics, biotechs can benefit from best-in-class applications that are pre-configured and validated, allowing for rapid deployment. This solution is built on the robust Vault Platform, which means companies can smoothly transition to a full Vault solution without the hassle of data migration. As the industry continues to evolve, having a flexible technology backbone is crucial for sustaining growth.
Driving Speed and Growth
During the recent Veeva R&D and Quality Summit held in Boston, leaders from over 60 biotech firms gathered to connect and discuss Veeva Basics's future. Steve Harper, the general manager of Veeva Basics, emphasized the enthusiastic reception and adaptability of their solutions. He stated, "We're committed to continually innovating and adding new applications that can be quickly implemented to facilitate the development of groundbreaking medicines."
New Applications to Enhance Quality Control
To meet the pressing demands of quality control and commercial operations, Veeva Basics is set to introduce two new applications:
- Veeva LIMS Basics: This application is designed for virtual biotech companies, providing essential features like oversight for Contract Manufacturing Organizations (CMO), batch release capabilities, and certificate of analysis (CoA) functionalities. Upcoming stability features are planned for release in 2026.
- Veeva PromoMats Basics: This application aims to streamline the full content lifecycle management process, which includes the approval, storage, and necessary distribution of promotional content and claims management.
Availability and Scalability
These applications are scheduled for availability in early 2026, and they are built on the reliable Vault Platform. Veeva Basics applications are designed to help customers expand their technology framework in line with their growth trajectories.
Feedback from Biotech Professionals
The reception of Veeva Basics among biotech professionals echoes the positive sentiment surrounding its usability and effectiveness. Richard Tornai, senior director of IT and R&D Clinical at Structure Therapeutics, shared his thoughts: "Veeva Basics has standardized our processes according to industry best practices. It provides us with an agile solution that ensures we can meet future requirements effortlessly."
Similarly, Bryan Ball, chief technical operations officer at Whitehawk Therapeutics, noted, "We aimed to establish a foundation for our compliance and regulatory operations, and Veeva Basics has exceeded those needs. It facilitates logical workflows and offers a library of templates and resources for efficient training."
Bernhard Irlinger, the head of quality at AiCuris, further commended Veeva Basics, stating, "It delivers superior solutions, and with global support, our staff can be trained swiftly. Veeva's dedication to biotechs and customer success is unparalleled."
About Veeva Systems
Veeva Systems is a leading provider of industry cloud solutions for life sciences. The company offers software, data, and consulting services with a strong commitment to innovation and customer satisfaction. Veeva serves over 1,500 clients, including major biopharmaceutical giants and emerging biotech firms. As a Public Benefit Corporation, Veeva focuses on the interests of all stakeholders such as customers, employees, shareholders, and the industries it serves.
Frequently Asked Questions
What is Veeva Basics?
Veeva Basics is a suite of applications designed for emerging biotech firms, providing streamlined solutions for clinical, regulatory, and quality operations.
How many companies have adopted Veeva Basics?
More than 100 biotech companies have selected Veeva Basics to enhance their operational processes.
What new applications are being introduced in Veeva Basics?
Veeva Basics is set to introduce Veeva LIMS Basics and Veeva PromoMats Basics, targeting quality control and content lifecycle management.
When will the new applications be available?
The new applications are planned for availability in early 2026.
How does Veeva Basics support biotech growth?
Veeva Basics provides scalable and pre-validated applications that can adapt to the evolving needs of biotech companies, facilitating operational efficiency and agility.
